Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data

Author:

van der Lee Maaike12ORCID,Allard William G.34,Vossen Rolf H. A. M.34,Baak-Pablo Renée F.1,Menafra Roberta34ORCID,Deiman Birgit A. L. M.5ORCID,Deenen Maarten J.16ORCID,Neven Patrick7,Johansson Inger8,Gastaldello Stefano8ORCID,Ingelman-Sundberg Magnus8,Guchelaar Henk-Jan12ORCID,Swen Jesse J.12ORCID,Anvar Seyed Yahya1234ORCID

Affiliation:

1. Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2333 ZA Leiden, Netherlands.

2. Leiden Network for Personalised Therapeutics, 2333 ZA Leiden, Netherlands.

3. Department of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, Netherlands.

4. Leiden Genome Technology Center, Leiden University Medical Center, 2333 ZA Leiden, Netherlands.

5. Clinical Laboratory, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, Netherlands.

6. Department of Clinical Pharmacy, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, Netherlands.

7. University Hospital Leuven, 3000 Leuven, Belgium.

8. Department of Physiology and Pharmacology, Karolinska Institutet, Biomedicum 5B, 171 77 Solna, Sweden.

Abstract

A neural network model trained on full CYP2D6 gene sequences increases the ability to predict CYP2D6-mediated tamoxifen metabolism.

Funder

Horizon 2020

ZonMW

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3